{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T21:21:02Z","timestamp":1780435262347,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ijaaonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.ijantimicag.2014.10.023","type":"journal-article","created":{"date-parts":[[2014,12,8]],"date-time":"2014-12-08T17:56:12Z","timestamp":1418061372000},"page":"268-277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Co-administration of glycyrrhizic acid with the antileishmanial drug sodium antimony gluconate (SAG) cures SAG-resistant visceral leishmaniasis"],"prefix":"10.1016","volume":"45","author":[{"given":"Amrita","family":"Bhattacharjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saikat","family":"Majumder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchandra Bhattacharyya","family":"Majumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumitra Kumar","family":"Choudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syamal","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subrata","family":"Majumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2014.10.023_bib0005","series-title":"WHO fact sheet no. 375","article-title":"Leishmaniasis","author":"World Health Organization","year":"2014"},{"key":"10.1016\/j.ijantimicag.2014.10.023_bib0010","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2014.10.023_bib0015","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1086\/318121","article-title":"Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic","volume":"31","author":"Sundar","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.10.023_bib0020","doi-asserted-by":"crossref","first-page":"571242","DOI":"10.4061\/2011\/571242","article-title":"Use of antimony in the treatment of leishmaniasis: current status and future directions","volume":"2011","author":"Haldar","year":"2011","journal-title":"Mol Biol Int"},{"key":"10.1016\/j.ijantimicag.2014.10.023_bib0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1368-7646(98)80213-6","article-title":"ABC transporters in Leishmania and their role in drug resistance","volume":"1","author":"Ouellette","year":"1998","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.ijantimicag.2014.10.023_bib0030","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1128\/AAC.01196-07","article-title":"Inhibition of ABC transporters abolishes antimony resistance in Leishmania infection","volume":"52","author":"Mookerjee Basu","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.10.023_bib0035","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1039\/c2np20035j","article-title":"Plants as sources of new antimicrobials and resistance-modifying agents","volume":"29","author":"Abreu","year":"2012","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.ijantimicag.2014.10.023_bib0040","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1126\/science.3544220","article-title":"Reversal of chloroquine resistance in Plasmodium falciparum by verapamil","volume":"235","author":"Martin","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.ijantimicag.2014.10.023_bib0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cbi.2009.04.013","article-title":"Hepatoprotective and anti-hepatocarcinogenic effects of glycyrrhizin and matrine","volume":"181","author":"Wan","year":"2009","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.ijantimicag.2014.10.023_bib0050","doi-asserted-by":"crossref","first-page":"e56020","DOI":"10.1371\/journal.pone.0056020","article-title":"Glycyrrhizic acid suppresses the development of precancerous lesions via regulating the hyperproliferation, inflammation, angiogenesis and apoptosis in the colon of Wistar rats","volume":"8","author":"Khan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2014.10.023_bib0055","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1124\/dmd.107.019513","article-title":"Inhibitory effects of terpenoids on multidrug resistance-associated protein 2- and breast cancer resistance protein-mediated transport","volume":"36","author":"Yoshida","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.ijantimicag.2014.10.023_bib0060","unstructured":"Majumdar S. A process for preparing pure glycyrrhizic acid from licorice. Patent application no. 771\/KOL\/2005. Govt. of India, International classification no. A61K\/31\/00, 2006."},{"key":"10.1016\/j.ijantimicag.2014.10.023_bib0065","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.4049\/jimmunol.166.6.4020","article-title":"Successful therapy of lethal murine visceral leishmaniasis with cystatin involves up-regulation of nitric oxide and a favorable T cell response","volume":"166","author":"Das","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.ijantimicag.2014.10.023_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.10.023_bib0075","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1248\/bpb.18.337","article-title":"Administration-route dependency of absorption of glycyrrhizin in rats: intraperitoneal administration dramatically enhanced bioavailability","volume":"18","author":"Yamamura","year":"1995","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.ijantimicag.2014.10.023_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/abio.1993.1223","article-title":"Antimony quantification in Leishmania by electrothermal atomic absorption spectroscopy","volume":"211","author":"Roberts","year":"1993","journal-title":"Anal Biochem"},{"key":"10.1016\/j.ijantimicag.2014.10.023_bib0085","doi-asserted-by":"crossref","first-page":"6828","DOI":"10.1128\/IAI.70.12.6828-6838.2002","article-title":"Leishmania donovani suppresses activated protein 1 and NF-\u03baB activation in host macrophages via ceramide generation: involvement of extracellular signal-regulated kinase","volume":"70","author":"Ghosh","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2014.10.023_bib0090","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0165-2478(90)90083-3","article-title":"Cellular mechanisms of nonspecific immunity to intracellular infection: cytokine-induced synthesis of toxic nitrogen oxides from l-arginine by macrophages and hepatocytes","volume":"25","author":"Green","year":"1990","journal-title":"Immunol Lett"},{"key":"10.1016\/j.ijantimicag.2014.10.023_bib0095","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/jac\/28.suppl_B.111","article-title":"Liposomal amphotericin B in the treatment of visceral leishmaniasis","volume":"28","author":"Croft","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.10.023_bib0100","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"Dorlo","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.10.023_bib0105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.exppara.2009.02.001","volume":"122","author":"Haldar","year":"2009","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.ijantimicag.2014.10.023_bib0110","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1128\/AAC.46.1.259-261.2002","article-title":"Combination therapy with indolylquinoline derivative and sodium antimony gluconate cures established visceral leishmaniasis in hamsters","volume":"46","author":"Pal","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.10.023_bib0115","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0924-8579(03)00203-6","article-title":"ABC-transporters: implications on drug resistance from microorganisms to human cancers","volume":"22","author":"Lage","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2014.10.023_bib0120","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1054\/drup.2001.0183","article-title":"The ABC transporter genes of Plasmodium falciparum and drug resistance","volume":"4","author":"Peel","year":"2001","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.ijantimicag.2014.10.023_bib0125","doi-asserted-by":"crossref","first-page":"11980","DOI":"10.1016\/S0021-9258(17)32670-4","article-title":"Contribution of the Leishmania P-glycoprotein-related gene ltpgpA to oxyanion resistance","volume":"269","author":"Papadopoulou","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijantimicag.2014.10.023_bib0130","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0014-5793(98)01716-5","article-title":"Overexpression of the multidrug resistance-associated protein (MRP1) in human heavy metal-selected tumor cells","volume":"443","author":"Vernhet","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ijantimicag.2014.10.023_bib0135","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/jac\/dkp500","article-title":"In vitro activity of anti-leishmanial drugs against Leishmania donovani is host cell dependent","volume":"65","author":"Seifert","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.10.023_bib0140","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/BF00933004","article-title":"Leishmania resistant to sodium stibogluconate: drug-associated macrophage-dependent killing","volume":"80","author":"Ibrahim","year":"1994","journal-title":"Parasitol Res"},{"key":"10.1016\/j.ijantimicag.2014.10.023_bib0145","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1128\/IAI.62.12.5498-5504.1994","article-title":"Depletion of interleukin-4 in BALB\/c mice with established Leishmania major infections increases the efficacy of antimony therapy and promotes Th1-like responses","volume":"62","author":"Nabors","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2014.10.023_bib0150","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1086\/315890","article-title":"Interleukin-12 regulates the response to chemotherapy in experimental visceral leishmaniasis","volume":"182","author":"Murray","year":"2000","journal-title":"J Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857914003616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857914003616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T01:44:33Z","timestamp":1650764673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857914003616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0924857914003616"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.10.023","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-administration of glycyrrhizic acid with the antileishmanial drug sodium antimony gluconate (SAG) cures SAG-resistant visceral leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}